LATEST ALERTS
CBD-Intel regulatory news in brief, 10th-16th April
16th April 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from France, Italy, Lithuania, Malta, Norway, Poland, Spain, Sweden, Ukraine and the US
Regulation and legislation
New Senate request could hold Mexican legalisation back until at least September
15th April 2021 - News analysis |
Mexico’s Senate is poised to request extra time to approve legislation that would legalise cannabis in the country, prolonging debate over the highly anticipated bill until September
Details of China’s proposed ban on CBD in cosmetics still unclear
14th April 2021 - News analysis |
Suggestions that a Chinese ban on the use of CBD in cosmetics that would essentially shut down the domestic CBD market, blocking imports and cross-border online sales, appear to be premature
‘Cautious’ Idaho is ready at last to become the 50th state to legalise industrial hemp
13th April 2021 - News analysis |
It’s been a long process getting there, but the last US state to legalise industrial hemp finally has a bill headed to the governor’s desk and farmers poised to plant the crop
Regulatory report: Denmark, April 2021
13th April 2021 - Regulatory reports |
Cultivation of hemp with less than 0.2% THC is legal in Denmark. This report provides an overview of the country’s regulatory framework for CBD, hemp and cannabis
CBD-Intel regulatory news in brief, 2nd-9th April
9th April 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Czech Republic, Belgium, the UK, Mexico and the US
A mixed bag: reactions to the USDA’s final hemp rule requirements
9th April 2021 - News analysis |
States continue to update their hemp production plans to match US Department of Agriculture (USDA) final rule requirements, with Michigan being one of the latest
Regulatory report: Sweden, April 2021
8th April 2021 - Regulatory reports |
This report offers an overview of the current regulatory framework in place for hemp, CBD and cannabis in Sweden
Regulatory report: Taiwan, April 2021
8th April 2021 - Regulatory reports |
This report provides an overview of the regulatory regime for CBD, hemp and cannabis in Taiwan
Should CBD companies operating in the US be worried about the latest round of FDA enforcement?
8th April 2021 - Blogs |
Four new letters sent by the US Food and Drug Administration (FDA) in the month of April mark a bit of a change in approach. Two of them were fairly standard warnings about health claim marketing potentially in violation of the Food Drug & Cosmetics (FD&C) Act. But the other two represented something different. For one, they came from a new FDA » Continue Reading.
Italy issues its first licences to grow hemp and extract CBD for medical use
8th April 2021 - News analysis |
Italy’s Ministry of Health and the Italian Medicine Agency (AIFA) have begun authorising Italian companies to manufacture hemp-derived CBD extracts for pharmaceutical purposes
Regulatory report: France, April 2021
8th April 2021 - Regulatory reports |
The future regulation, and interpretation of existing rules, of cannabis in all its forms is a recurring subject in France. This report provides an overview of the current regulatory framework
Germany’s highest court leaves legality of hemp flowers open to interpretation
6th April 2021 - News analysis |
Germany’s highest civil and criminal court has ruled that low-THC industrial hemp flowers may be considered a narcotic – but that they can be legally sold to German consumers if there is no risk of intoxication
CBD-Intel regulatory news in brief, 27th March-1st April
1st April 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the Cyprus. Czech Republic, the EU, Finland, France, Germany, Iceland, Malta, Switzerland, the US, and Argentina
Now that the deadline for applications has passed, when should enforcement action from the UK Food Standards Agency (FSA) be expected?
1st April 2021 - Blogs |
The FSA told CBD-Intel during a recent conference that – unsurprisingly – no actions would be taken until after the list of validated/administratively checked pending validation applications had been published. Thus far no date for the publication of the list has been put forward, but the speculation is that it will now more than likely be at least May before it » Continue Reading.
Regulatory report: South Africa, April 2021
1st April 2021 - Regulatory reports |
This report covers the current regulatory regime for hemp, CBD and cannabis in South Africa, including the regimes for medical and recreational cannabis
Could Oregon state bill show a way out of US cannabis and CBD banking troubles?
30th March 2021 - News analysis |
An Oregon senator believes he has found a solution to the cannabis banking crisis in the state, and perhaps set a useful standard for others across the US
Regulatory report: financial services for CBD companies in the US
30th March 2021 - Regulatory reports |
This report addresses the reasons why CBD and cannabis-related businesses in the US have trouble obtaining banking and payment processing services, what they can do, and what might be done to address the problem
CBD-Intel regulatory news in brief, 20th-26th March
26th March 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the EU, France, Germany, the UK, the US, China and Thailand
Was the UK FSA decision to make changes to the novel food application timeline really that unexpected?
25th March 2021 - Blogs |
The UK Food Standards Agency (FSA) has ruffled a few feathers by changing its criteria for allowing products to stay on the market. Instead of requiring a validated novel food submission, it now only requires a submission that has been administratively checked (essentially scanned over to make sure all required bits are present) – under the assumption that the application » Continue Reading.
Podcast: what lies beyond North America’s legal cannabis market?
22nd March 2021 - Podcasts , Resources |
Podcasts editor Jon Bruford is joined by Anthony Traurig, CBD-Intel legal analyst and US specialist, to discuss the legal and regulatory concerns that hang over cannabis in the US and Canada and the economic impact of Covid-19
CBD-Intel regulatory news in brief, 13th-19th March
19th March 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Belgium, France, Italy, Slovakia, the UK, Canada, the US and South Africa
Regulatory report: Poland, March 2021
19th March 2021 - Regulatory reports |
This report offers an overview of the current regulations in place for CBD and cannabis in Poland, including all aspects from cultivation and processing, to finished products, medical and recreational cannabis
Not now, but soon – new industry bodies prepare for Brazil opening up to hemp
18th March 2021 - News analysis |
Brazil still faces a serious attitude problem when it comes to advancing regulations for hemp and CBD, according to the leaders of two recently launched industry associations in the country
CBD-Intel regulatory news in brief, 6th-12th March
12th March 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Czech Republic, France, Greece, Switzerland, Canada, the UK, Mexico, the US, Costa Rica, China, Morocco and Taiwan
Will the FSA-validated novel food submission list reveal commercially sensitive information?
11th March 2021 - Blogs |
There’s been some worry that the eventual list of brands with a novel food application validated by the UK Food Standards Agency (FSA) will reveal commercially sensitive information such as which brands are currently contracted to which ingredient or white-label goods suppliers. But the FSA has not indicated that such information would be included in any list. And there is » Continue Reading.
Armenia looks to hemp legalisation as part of a route out of national crisis
10th March 2021 - News analysis |
Crisis-hit Armenia intends to legalise and regulate the production of hemp as a part of a package of economic measures to alleviate issues arising from the military conflict with Azerbaijan over the Nagorno-Karabakh region
Podcast: the changing regulatory environment for cannabis in the US
9th March 2021 - Podcasts , Resources |
CBD-Intel podcasts editor Jon Bruford is joined by the founder and principal of Kight Law Office, Rod Kight, a specialist in cannabis business law in the US
Pakistan moves towards a legal hemp industry under the eye of government
8th March 2021 - News analysis |
Pakistan is set to embark on a path to the legal production of hemp and hemp-derived products following the approval last September of hemp farming and processing under government control
CBD-Intel regulatory news in brief, 27th February-5th March
5th March 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Germany, France, Luxembourg, Malta, Poland, Spain, Mexico, the US, Brazil and Zambia
UK FSA picks up the pace with at least one novel food application validated
5th March 2021 - News analysis |
The UK Food Standards Agency (FSA) is moving forward at pace with at least one CBD novel food application having been validated
How long will it take to see validated assessments from the UK Food Standards Agency (FSA)?
4th March 2021 - Blogs |
The FSA has confirmed to CBD-Intel that it has already validated at least one application with an updated list to be published in April. This represents a significantly quicker turnaround than many anticipated, though Pureis did submit its application as soon as possible – telling CBD-Intel that it filed it one minute after midnight on 1st January 2021. However assuming » Continue Reading.
‘Outdated’ Japanese import and growing restrictions may get even tougher
4th March 2021 - News analysis |
Tough Japanese laws on the import of CBD products and the cultivation of industrial hemp are becoming more challenging for the industry – and even stricter regulations may be on the way
Regulatory report: US – importing and exporting hemp and CBD products
1st March 2021 - Regulatory reports |
This report examines the legal requirements and practical considerations when importing to and exporting from the largest CBD market in the world – the US
CBD-Intel regulatory news in brief, 20-26th February
26th February 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Germany, Iceland, Norway, the UK, the US, Colombia, Ghana, Japan, Morocco, Pakistan and Thailand
Could the Biden administration bring a new approach to enforcement of CBD health claims?
26th February 2021 - Blogs |
There is a chance that enforcement priorities could change under new appointments to the Federal Trade Commission (FTC) by the Biden administration. Two commissioners – one of which is staying on to work as part of the Republican minority of the five-commissioner panel in charge of the FTC, and the other of which appears to have some influence on their likely » Continue Reading.
Governor’s influence questioned after judge blocks cannabis legalisation
23rd February 2021 - News analysis |
The legalisation of recreational cannabis in South Dakota is in doubt, amidst accusations of political interference after a judge appointed by the state governor ruled the voter-approved amendment unconstitutional
Podcast: cold-pressed technology, novel food guidelines and the impact of Brexit
22nd February 2021 - Podcasts , Resources |
Jon Bruford, CBD-Intel’s podcasts editor, is joined by the CEO & co-founder of the Greenheart CBD Ltd, Mark Canavan, an Irish-owned company that produces and sells CBD oil made from Irish-grown hemp
CBD-Intel regulatory news in brief, 13th-19th February
19th February 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Belgium, the EU, the UK the US and Thailand
Have the rules changed for importation of CBD into the UK?
18th February 2021 - Blogs |
The Home Office has not changed licensing requirements for importers of CBD into the UK. The minister for policing, Christopher “Kit” Malthouse, has requested an updated recommendation from the Advisory Council on the Misuse of Drugs (ACMD) on acceptable THC levels in CBD consumer products. The ACMD has not yet responded and the previous limit of 1 mg generic tolerance for » Continue Reading.
Podcast: are changes to the Philippine’s regulatory framework likely in the near future?
17th February 2021 - Podcasts , Resources |
Our host for today’s podcast is Jon Bruford, a copy editor at CBD-Intel, who will be joined by CBD-Intel junior legal analyst Elsa Carrasco, who discusses the current regulatory framework in place for CBD and cannabis in the Philippines. Elsa presents a clear idea of the legal framework of the country, the requirements to operate in the CBD industry in » Continue Reading.
Regulatory report: Netherlands, February 2021
15th February 2021 - Regulatory reports |
The broad legal framework for hemp, CBD and medical cannabis in the Netherlands will remain unchanged for now due to upcoming parliamentary elections. This report covers the current rules for cannabis and CBD
Will the EFSA look to modify its approach in light of action on novel food in the UK?
12th February 2021 - Blogs |
The European Food Safety Authority (EFSA) has stated that it is in contact with other similar agencies such as the Food Standards Agency (FSA) in the UK, but only specified that it would not treat applications that had been approved in other jurisdictions any differently during its own assessment process. But beyond that, it has not stated what other influence the FSA » Continue Reading.
CBD-Intel regulatory news in brief, 6th-12th February
12th February 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Belgium, France, Slovakia, the US, Armenia, Brazil and Thailand
No Home Office change in CBD importation licensing requirements
12th February 2021 - News analysis |
Reports that the UK Home Office now requires businesses importing CBD into the UK to have controlled drug licences are untrue, according to the Home Office
Is this the year? US cannabis and CBD law reform efforts worth watching in 2021
11th February 2021 - News analysis |
The Democratic Party, which now controls Congress and the presidency, has signalled for some time that cannabis reform is one of its top priorities, and the US public supports that reform in unprecedented numbers
Regulatory report: Canada, February 2021
8th February 2021 - Regulatory reports |
Canada permits the cultivation, production, distribution, and sale of hemp, cannabis, and products derived from them, but only by those licensed to do so by the government. This report offers a detailed overview of the rules
CBD-Intel regulatory news in brief, 30th January-5th February
5th February 2021 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the EU, France, Greece, Italy, the UK, Canada, the US, Australia, China, Israel and Sri Lanka
How seriously should producers of CBD alcohol products take the recent Portman Group ruling?
5th February 2021 - Blogs |
The Portman Group’s first decision on a complaint regarding a CBD product has gone largely unreported but could have a very significant impact on that part of the market. The voluntary alcohol industry regulator has said it is bringing out further guidance for producers of CBD alcoholic beverages – the first time it will have addressed the issue. So it is important to » Continue Reading.
European CBD Landscape 2021 and Beyond – Markets, Products & Consumers Trends
2nd February 2021 - Presentations , Resources |
CBD-Intel’s managing director, Tim Phillips, recently presented on the major global factors seen in the CBD industry in 2020, key pricing and product evolution throughout the year, and what to expect in 2021 during the GCI Virtual Summit. Tim analyses the shifts in consumer preferences and business developments – as well as challenges and opportunities of the sector. You can » Continue Reading.
